A. Loboda

发表

EMT is the dominant program in human colon cancer

David B Jackson, David B. Jackson, T. Yeatman, 2011, BMC Medical Genomics.

Comparative expression pathway analysis of human and canine mammary tumors

J. Castle, G. Ciliberto, A. Kulkarni, 2009, BMC Genomics.

Network-driven plasma proteomics expose molecular changes in the Alzheimer’s brain

E. D. Kirby, T. Ideker, B. Miller, 2016, Molecular Neurodegeneration.

A gene expression signature of RAS pathway dependence predicts response to PI3K and RAS pathway inhibitors and expands the population of RAS pathway activated tumors

C. Paweletz, H. Dai, I. Feldman, 2010, BMC Medical Genomics.

A Composite Gene Expression Signature Optimizes Prediction of Colorectal Cancer Metastasis and Outcome

Charlotte Soneson, Timothy J. Yeatman, Michael J. Schell, 2015, Clinical Cancer Research.

A multigene mutation classification of 468 colorectal cancers reveals a prognostic role for APC

Timothy J. Yeatman, Michael J. Schell, Jamie K. Teer, 2016, Nature Communications.

Biomarker Discovery: Identification of a Growth Factor Gene Signature

H. Dai, A. Loboda, A. Loboda, 2009, Clinical pharmacology and therapeutics.

articleA gene expression signature of RAS pathway dependence predicts response to PI 3 K and RAS pathway inhibitors and expands the population of RAS pathway activated tumors

C. Paweletz, H. Dai, I. Feldman, 2010 .

articleA gene expression signature of RAS pathway dependence predicts response to PI 3 K and RAS pathway inhibitors and expands the population of RAS pathway activated tumors

C. Paweletz, H. Dai, I. Feldman, 2010 .